Craft

Legend Biotech

Stock Price

$60.5

2023-11-24

Market Capitalization

$11 B

2023-11-24

Revenue

$117 M

FY, 2022

Legend Biotech Summary

Company Summary

Overview
Legend Biotech is a biopharmaceutical company engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma.
Type
Public
Status
Active
Founded
2014
HQ
Somerset, NJ, US | view all locations
Website
http://www.legendbiotech.com/index.php
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Frank Fan

    Frank Fan, Co-Founder & Chief Scientific Officer

  • Ying Huang

    Ying Huang, Chief Financial Officer

  • Meeta Chatterjee

    Meeta Chatterjee, Senior Vice President, Global Business Development

  • Tracy Luo

    Tracy Luo, Vice President, Clinical Development

    LocationsView all

    5 locations detected

    • Somerset, NJ HQ

      United States

      2101 Cottontail Lane

    • Piscataway, NJ

      United States

      10 Knightsbridge Road

    • Ghent, Vlaams Gewest

      Belgium

      Technologiepark 122

    • Nanjing

      China

      No. 6 Building, Life Science TechTown, 568 Longmian Avenue

    • Dublin, County Dublin

      Ireland

      10A Ballymoss Road, Sandyford Business Park

    Legend Biotech Financials

    Summary Financials

    Revenue (FY, 2022)
    $117.0M
    Gross profit (FY, 2022)
    $51.6M
    Net income (FY, 2022)
    ($446.3M)
    Cash (FY, 2022)
    $786.0M
    Enterprise value
    $10.5B

    Footer menu